|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Other revenues | |||||
| Revenues, gross | |||||
| Product Sales | |||||
| Technology Enabled Services | |||||
| Total revenues, gross | |||||
| Sales returns and allowances | |||||
| Total revenues, net | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income / (expense): | |||||
| Interest Income | |||||
| Change in fair value of warranty liabilities | |||||
| Other | |||||
| Total other income / (expense), net | |||||
| Net loss | |||||
| Comprehensive loss | |||||
| Less: Convertible preferred stock dividends | |||||
| Net loss attributable to common stockholders | |||||
| Net unrealized gain on short-term investments | |||||
| Net loss per basic share of Common Stock (in Dollars per share) | |||||
| Net loss per diluted share of Common Stock (in Dollars per share) | |||||
| Weighted average shares of Common Stock used to compute net loss per basic shares of Common Stock (in Shares) | |||||
| Weighted average shares of Common Stock used to compute net loss per diluted shares of Common Stock (in Shares) | |||||
Loading...